Cybersecurity Architect - Mergers & Acquisitions

    United States
    Full-Time
    Mid (3-6 yrs)
    IT & Security
    Posted on October 8, 2026

    AbbVie is looking for a Security Architect with experience in mergers and acquisitions to join our Information Security & Risk Management (ISRM) Security Architecture team. AbbVie’s Information Security group engages with our business development teams through several stages of a company relationship, whether it is a research-sharing relationship or an acquisition. We provide advisory services to reduce both risk and technical friction in these transactions.

    As a Security Architect, you will act as a single-point-of-contact between security and other technical and business teams, operating across both operational and strategic levels, developing and coordinating design and advisory responsibilities with different areas of the information security group on individual acquisitions and research ventures. You will interact with internal research and business intelligence teams, technical teams, and other members of the information security group to develop and deliver security products and services. You will play a key role in further shaping the services this program is delivering, while ensuring in-flight acquisitions have the right security services provided at the right times.

    This role will reside within the security architecture team, with a “dotted line” relationship with our cybersecurity threat intelligence team.

    This position can be virtual/remote anywhere in U.S.

    Responsibilities:

    • Partner with infrastructure and technology teams, security teams, and acquisition target teams to coordinate core security and tech services during acquisition or divestiture.
    • Partnering with infrastructure, tech and security teams to develop, document, and deploy secure design patterns for collaborations with strategic alliance partners.
    • Partner with internal security and technical teams to develop new security playbooks and services focused on business alliances and strategic acquisitions.

    Company:  AbbVie

    Develops biopharmaceutical therapies focused on immunology, oncology, neuroscience, and specialty care.
    10001+ employees
    Healthcare & Life Sciences
    HQ: United States